Insiders · Profile

Edris Badreddin

Director at Edgewise Therapeutics. Filing since 21 Jan 2026. CIK 0001786966

Company

Date

Role

Action

Shares

Amount

Of holding

EWTX Edgewise Therapeutics, Inc.

21 Jan 2026

Director

Sold on a plan

115,471

$3.40M

85.4%

1 decision on file.